Document is current
Any future updates will be listed below
-
Authors
Wang, Qianqian
Lv, Nan
Xu, Dong
Wu, Yang
Wu, Junli
Gao, Wentao
Wei, Jishu
Xiao, Bin
Tu, Min
Jiang, Kuirong
-
Funding
Funding for this research was provided by:
Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University (PY202424)
Jangsu Province Hlospital (the First Affiliated Hospital with Nanjing Medical University) Clinical Capacity Enhancement Project (JSPH-MB-2023-12)
Development Cancer for Medical Science & Technology National Health Commission of the People’s Republic of China "Innovative Drug post-marketing Clinical Research Research Project" (WKZX2024CX102203)
- License Information
-
More Information
Article History
Received: 27 March 2025
Accepted: 27 June 2025
First Online: 24 July 2025
Declarations
:
: The study was approved by the First Affiliated Hospital of Nanjing Medical University Ethics Committee and complied with the ethical standards of the Declaration of Helsinki. All participants gave their written informed consent at registry inclusion.
: Not applicable.
: The authors declare no competing interests.
